MERAL Myanmar Education Research and Learning Portal
Item
{"_buckets": {"deposit": "bf0e9fb4-5d37-4daa-836b-b183ee933c6c"}, "_deposit": {"created_by": 37, "id": "5758", "owner": "37", "owners": [37], "owners_ext": {"displayname": "", "username": ""}, "pid": {"revision_id": 0, "type": "recid", "value": "5758"}, "status": "published"}, "_oai": {"id": "oai:meral.edu.mm:recid/5758", "sets": ["user-um1"]}, "communities": ["um1"], "item_1583103067471": {"attribute_name": "Title", "attribute_value_mlt": [{"subitem_1551255647225": "Plasma Microrna-21 Expression in Patients with Non-small Cell Lung Cancer", "subitem_1551255648112": "en"}]}, "item_1583103085720": {"attribute_name": "Description", "attribute_value_mlt": [{"interim": "Lung cancer is one of the most common malignancies and is also the leading cancer-related death worldwide. Majority of which are non-small cell lung cancers. Five year survival rate of stage IV non-small cell lung cancer is approximately only 10% whereas for stage I disease, it can be as high as 80%. These data provide the rationale to improve the diagnosis of non-small cell lung cancer and to detect the disease at an earlier stage where the cure of the disease can be expected."}]}, "item_1583103120197": {"attribute_name": "Files", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_access", "date": [{"dateType": "Available", "dateValue": "2020-10-14"}], "displaytype": "preview", "download_preview_message": "", "file_order": 0, "filename": "1_Dr Yin Mon Thant_Chest Medical.pdf", "filesize": [{"value": "164 Kb"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_1", "mimetype": "application/pdf", "size": 164000.0, "url": {"url": "https://meral.edu.mm/record/5758/files/1_Dr Yin Mon Thant_Chest Medical.pdf"}, "version_id": "eda89e60-f5f8-40e4-badf-b9013aa38851"}]}, "item_1583103131163": {"attribute_name": "Journal articles", "attribute_value_mlt": [{"subitem_issue": "1", "subitem_journal_title": "Research Journal UM1", "subitem_pages": "79-87", "subitem_volume": "1"}]}, "item_1583105942107": {"attribute_name": "Authors", "attribute_value_mlt": [{"subitem_authors": [{"subitem_authors_fullname": "Yin Mon Thant"}, {"subitem_authors_fullname": "Win Naing"}, {"subitem_authors_fullname": "Toe Sandar"}]}]}, "item_1583108359239": {"attribute_name": "Upload type", "attribute_value_mlt": [{"interim": "Publication"}]}, "item_1583108428133": {"attribute_name": "Publication type", "attribute_value_mlt": [{"interim": "Journal article"}]}, "item_1583159729339": {"attribute_name": "Publication date", "attribute_value": "2020-02-15"}, "item_title": "Plasma Microrna-21 Expression in Patients with Non-small Cell Lung Cancer", "item_type_id": "21", "owner": "37", "path": ["1597649727009"], "permalink_uri": "http://hdl.handle.net/20.500.12678/0000005758", "pubdate": {"attribute_name": "Deposited date", "attribute_value": "2020-10-14"}, "publish_date": "2020-10-14", "publish_status": "0", "recid": "5758", "relation": {}, "relation_version_is_last": true, "title": ["Plasma Microrna-21 Expression in Patients with Non-small Cell Lung Cancer"], "weko_shared_id": -1}
Plasma Microrna-21 Expression in Patients with Non-small Cell Lung Cancer
http://hdl.handle.net/20.500.12678/0000005758
http://hdl.handle.net/20.500.12678/00000057584f64589e-97c8-455a-8e0e-800ad49f4804
bf0e9fb4-5d37-4daa-836b-b183ee933c6c
Name / File | License | Actions |
---|---|---|
1_Dr Yin Mon Thant_Chest Medical.pdf (164 Kb)
|
Publication type | ||||||
---|---|---|---|---|---|---|
Journal article | ||||||
Upload type | ||||||
Publication | ||||||
Title | ||||||
Title | Plasma Microrna-21 Expression in Patients with Non-small Cell Lung Cancer | |||||
Language | en | |||||
Publication date | 2020-02-15 | |||||
Authors | ||||||
Yin Mon Thant | ||||||
Win Naing | ||||||
Toe Sandar | ||||||
Description | ||||||
Lung cancer is one of the most common malignancies and is also the leading cancer-related death worldwide. Majority of which are non-small cell lung cancers. Five year survival rate of stage IV non-small cell lung cancer is approximately only 10% whereas for stage I disease, it can be as high as 80%. These data provide the rationale to improve the diagnosis of non-small cell lung cancer and to detect the disease at an earlier stage where the cure of the disease can be expected. | ||||||
Journal articles | ||||||
1 | ||||||
Research Journal UM1 | ||||||
79-87 | ||||||
1 |